What is Juvenile Myoclonic Epilepsy? Juvenile myoclonic epilepsy (JME) is an epileptic condition that develops in children and adolescents, invariably between the ages of 8 and 26 with most of the ...

Q: Is there a cure for myoclonic epilepsy? A: Yes, juvenile myoclonic epilepsy (JME) can be treated with medications. With the appropriate drugs, the condition can be managed and may, in some cases, ...

NEW YORK (Reuters Health), Jan 7 - While dental injury during seizures is rare in patients with epilepsy, it occurs more frequently in those with juvenile myoclonic epilepsy (JME), according to ...

Brain Activity Linked to TNF Inhibitor Response in RA Juvenile myoclonic epilepsy (JME) is a heterogeneous epilepsy syndrome and life-long antiepileptic drug (AED) treatment is not required in all ...

A 25-year follow-up study reveals that 68% of patients with juvenile myoclonic epilepsy (JME) became seizure-free, with nearly 30% no longer needing antiepileptic drug (AED) treatment. A 25-year ...

What Is Juvenile Myoclonic Epilepsy (JME)? Also known as Janz syndrome, JME is a common generalised epilepsy disorder that typically begins in adolescence or early adulthood. It is characterised by ...

Epilepsy is not a one size fits all condition and there are a few tell tale signs that parents could miss, said Dr Jonathan ...

Research groups have described in collaboration a novel myoclonic epilepsy in dogs and identified its genetic cause. The study reveals a novel candidate gene for human myoclonic epilepsies, one of the ...